288 related items for PubMed ID: 7883833
1. The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion.
Torpy DJ, Grice JE, Hockings GI, Crosbie GV, Walters MM, Jackson RV.
J Clin Endocrinol Metab; 1995 Mar; 80(3):802-6. PubMed ID: 7883833
[Abstract] [Full Text] [Related]
2. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
[Abstract] [Full Text] [Related]
3. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
Dorin RI, Ferries LM, Roberts B, Qualls CR, Veldhuis JD, Lisansky EJ.
J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
[Abstract] [Full Text] [Related]
4. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.
Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
J Clin Endocrinol Metab; 1993 Feb; 76(2):388-91. PubMed ID: 8381800
[Abstract] [Full Text] [Related]
5. Effect of sodium valproate on naloxone-stimulated ACTH and cortisol release in humans.
Torpy DJ, Grice JE, Hockings GI, Crosbie GV, Walters MM, Jackson RV.
Clin Exp Pharmacol Physiol; 1995 Feb; 22(6-7):441-3. PubMed ID: 8582096
[Abstract] [Full Text] [Related]
6. Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and modulation by chronic treatment with desipramine.
Bondi CO, Barrera G, Lapiz MD, Bedard T, Mahan A, Morilak DA.
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar 30; 31(2):482-95. PubMed ID: 17188790
[Abstract] [Full Text] [Related]
7. Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.
Hockings GI, Grice JE, Crosbie GV, Walters MM, Jackson AJ, Jackson RV.
J Clin Endocrinol Metab; 1993 Aug 30; 77(2):404-8. PubMed ID: 8393884
[Abstract] [Full Text] [Related]
8. Effect of flumazenil on basal and naloxone-stimulated ACTH and cortisol release in humans.
Torpy DJ, Jackson RV, Grice JE, Hockings GI, Crosbie GV, Walters MM.
Clin Exp Pharmacol Physiol; 1994 Feb 30; 21(2):157-61. PubMed ID: 8039271
[Abstract] [Full Text] [Related]
9. Elevated basal adrenocorticotropin and evidence for increased central opioid tone in highly trained male athletes.
Inder WJ, Hellemans J, Ellis MJ, Evans MJ, Livesey JH, Donald RA.
J Clin Endocrinol Metab; 1995 Jan 30; 80(1):244-8. PubMed ID: 7829620
[Abstract] [Full Text] [Related]
10. Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans.
Arvat E, Maccagno B, Giordano R, Pellegrino M, Broglio F, Gianotti L, Maccario M, Camanni F, Ghigo E.
J Clin Endocrinol Metab; 2001 Jul 30; 86(7):3176-81. PubMed ID: 11443185
[Abstract] [Full Text] [Related]
11. Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain.
Lacroix D, Blier P, Curet O, de Montigny C.
J Pharmacol Exp Ther; 1991 Jun 30; 257(3):1081-90. PubMed ID: 1646320
[Abstract] [Full Text] [Related]
12. Effects of carbamazepine on pituitary-adrenal function in healthy volunteers.
Perini GI, Devinsky O, Hauser P, Gallucci WT, Theodore WH, Chrousos GP, Gold PW, Kling MA.
J Clin Endocrinol Metab; 1992 Feb 30; 74(2):406-12. PubMed ID: 1309836
[Abstract] [Full Text] [Related]
13. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia.
Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR.
Arthritis Rheum; 2000 Apr 30; 43(4):872-80. PubMed ID: 10765933
[Abstract] [Full Text] [Related]
14. Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy.
Buyalos RP, Jackson RV, Grice GI, Hockings GI, Torpy DJ, Fox LM, Boots LR, Azziz R.
J Clin Endocrinol Metab; 1998 Sep 30; 83(9):3219-24. PubMed ID: 9745431
[Abstract] [Full Text] [Related]
15. Dynamics of the regulation of the hypothalamo-pituitary-adrenal (HPA) axis determined using a nonsurgical method for collecting pituitary venous blood from horses.
Alexander SL, Irvine CH, Donald RA.
Front Neuroendocrinol; 1996 Jan 30; 17(1):1-50. PubMed ID: 8788568
[Abstract] [Full Text] [Related]
16. Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axis.
Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
Clin Exp Pharmacol Physiol; 1997 Jun 30; 24(6):421-3. PubMed ID: 9171947
[Abstract] [Full Text] [Related]
17. Cerebrospinal fluid corticotropin-releasing hormone in healthy humans: effects of yohimbine and naloxone.
Vythilingam M, Anderson GM, Owens MJ, Halaszynski TM, Bremner JD, Carpenter LL, Heninger GR, Nemeroff CB, Charney DS.
J Clin Endocrinol Metab; 2000 Nov 30; 85(11):4138-45. PubMed ID: 11095445
[Abstract] [Full Text] [Related]
18. Evidence that the central noradrenergic and adrenergic pathways activate the hypothalamic-pituitary-adrenal axis in the sheep.
Liu JP, Clarke IJ, Funder JW, Engler D.
Endocrinology; 1991 Jul 30; 129(1):200-9. PubMed ID: 1647297
[Abstract] [Full Text] [Related]
19. The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
Korbonits M, Kaltsas G, Perry LA, Putignano P, Grossman AB, Besser GM, Trainer PJ.
J Clin Endocrinol Metab; 1999 Jul 30; 84(7):2489-95. PubMed ID: 10404825
[Abstract] [Full Text] [Related]
20. Influence of exogenous atrial natriuretic peptide on the pituitary-adrenal response to corticotropin-releasing hormone and vasopressin in healthy men.
Bierwolf C, Burgemeister A, Lüthke K, Born J, Fehm HL.
J Clin Endocrinol Metab; 1998 Apr 30; 83(4):1151-7. PubMed ID: 9543132
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
